3,079 results
Search Results
152. Impact of cachexia on pharmacokinetic disposition of and clinical responses to oxycodone in cancer patients
153. Pharmacokinetics of fondaparinux 1.5 mg once daily in a real-world cohort of patients with renal impairment undergoing major orthopaedic surgery
154. Clinical relations of methotrexate pharmacokinetics in the treatment for pediatric osteosarcoma
155. Entry-into-humans study with a new direct renin inhibitor
156. Pharmakotherapie im Alter aus internistisch-pneumologischer Sicht
157. Pharmacokinetic study of unbound forsythiaside in rat blood and bile by microdialysis coupled with HPLC method
158. Influence of UGT genetic polymorphism on the interindividual variability in mitiglinide pharmacokinetic in Chinese
159. Concurrent administration of atypical antipsychotics and donepezil: drug interaction study in rats
160. Degree of freezing does not affect efficacy of frozen gloves for prevention of docetaxel-induced nail toxicity in breast cancer patients
161. Pharmacokinetics of sepantronium bromide (YM155), a small-molecule suppressor of survivin, in Japanese patients with advanced solid tumors: dose proportionality and influence of renal impairment
162. Phase I study of the Aurora B kinase inhibitor barasertib (AZD1152) to assess the pharmacokinetics, metabolism and excretion in patients with acute myeloid leukemia
163. CYP2C19 polymorphism affects single-dose pharmacokinetics of oral pantoprazole in healthy volunteers
164. Blood levels of pyrazinamide in children at doses administered under the revised national tuberculosis control program
165. Investigating the barriers to bioavailability of macrolide antibiotics in the rat
166. Effect of dose and dosage interval on the oral bioavailability of docetaxel in combination with a curcumin self-emulsifying drug delivery system (SEDDS)
167. Effect of nebivolol on beat-to-beat and short-term blood pressure variability in spontaneously hypertensive rats
168. Effect of age and gender on pharmacokinetics and pharmacodynamics of a single ticagrelor dose in healthy individuals
169. Automated On-Line SPE/Multi-Stage Column-Switching and Benzoic Acid-Based QAMS/RODWs-HPLC for Oral Pharmacokinetics of Syringic Acid and Salicylic Acid in Rats
170. Toxicity of amphetamines: an update
171. Effect of abiraterone acetate plus prednisone on the QT interval in patients with metastatic castration-resistant prostate cancer
172. The prognostic value of serum methotrexate area under curve in elderly primary CNS lymphoma patients
173. Population pharmacokinetic/pharmacodynamic modeling of drug-induced adverse effects of a novel homocamptothecin analog, elomotecan (BN80927), in a Phase I dose finding study in patients with advanced solid tumors
174. Serum concentrations of opioids when comparing two switching strategies to methadone for cancer pain
175. Arterial input function calculation in dynamic contrast-enhanced MRI: an in vivo validation study using co-registered contrast-enhanced ultrasound imaging
176. Pharmacokinetics and pharmacodynamics of the novel PAR-1 antagonist vorapaxar in patients with end-stage renal disease
177. Evaluation of the effect of food on the pharmacokinetics of axitinib in healthy volunteers
178. Description of a novel approach for intraperitoneal drug delivery and the related device
179. Single- and multiple-dose pharmacokinetics, safety and tolerability of zibotentan (ZD4054) in Chinese men with advanced solid tumors
180. Pharmakotherapie bei Patienten mit chronischer Nierenkrankheit
181. Comparison of a homologous series of benzonaphthyridine anti-cancer agents in mice: divergence between tumour and plasma pharmacokinetics
182. Single-dose intravenous casopitant in combination with ondansetron and dexamethasone for the prevention of oxaliplatin-induced nausea and vomiting: a multicenter, randomized, double-blind, active-controlled, two arm, parallel group study
183. A phase I study of sunitinib combined with modified FOLFOX6 in patients with advanced solid tumors
184. The minimal impact of food on the pharmacokinetics of ridaforolimus
185. Determination of Boc5 in Rat Plasma by HPLC–MS/MS and Its Application to a Pharmacokinetic Study
186. Modeling and simulation approaches to evaluate pharmacokinetic sampling contamination from central venous catheters in pediatric pharmacokinetic studies of actinomycin-D: a report from the children’s oncology group
187. Preclinical pharmacology of novel indolecarboxamide ML-970, an investigative anticancer agent
188. Interactions pharmacocinétiques entre préparation à base de plantes et médicament : une revue de l’importance clinique
189. Population pharmacokinetics of plasma-derived factor IX in adult patients with haemophilia B: implications for dosing in prophylaxis
190. 9-Amino acridine pharmacokinetics, brain distribution, and in vitro/in vivo efficacy against malignant glioma
191. Impact of CYP2D6 polymorphisms on the pharmacokinetics of lovastatin in Chinese subjects
192. Probiotics decreased the bioavailability of the bile acid analog, monoketocholic acid, when coadministered with gliclazide, in healthy but not diabetic rats
193. Effect of pomegranate juice on the pharmacokinetics of nitrendipine in rabbits
194. Pharmacokinetics of vitexin-4″-O-glucoside in rats after intravenous application
195. Open-label, phase I, pharmacokinetic studies of abiraterone acetate in healthy men
196. The effect of aprepitant and race on the pharmacokinetics of cyclophosphamide in breast cancer patients
197. The effect of multiple doses of rifampin and ketoconazole on the single-dose pharmacokinetics of ridaforolimus
198. Novel electrophilic synthesis of 6-[18F]fluorodopamine and comprehensive biological evaluation
199. Repeat-dose sirolimus pharmacokinetics and pharmacodynamics in patients with hepatic allografts
200. Switching from enoxaparin to dabigatran etexilate: pharmacokinetics, pharmacodynamics, and safety profile
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.